ARGX argenx SE ADRs
argenx SE, along with its subsidiaries is engaged in the bio-technical research on drugs and pharma processes for the treatment of oncological, autoimmune and inflammatory diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol NA:ARGX.
$374.17 +9.82 (2.70%)
As of 06/27/2022 15:59:54 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
ADRsCategory3:
Large cap
GICS sector: Health Care
Industry: Biotechnology
Index country: The Netherlands
Country of incorporation: The Netherlands
IPO date: 05/18/2017
Outstanding shares: 53,619,013
Average volume: 318,838
Market cap: $19,546,811,189
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Annual filings:
20-F
Sedol: BDVLM39
Valuation (See tab for details)
PE ratio: -60.73
PB ratio: 7.43
PS ratio: 38.69
Return on equity: -10.90%
Net income %: -63.66%